These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6200330)

  • 21. A specific and sensitive sandwich enzyme immunoassay for human chorionic gonadotropin using antibodies against the carboxyl-terminal portion of the beta-subunit.
    Kondo K; Imagawa M; Iwasa S; Kitada C; Konishi E; Suzuki N; Yamoto M; Nakano R; Yoshitake S; Ishikawa E
    Clin Chim Acta; 1984 Apr; 138(2):229-35. PubMed ID: 6327121
    [No Abstract]   [Full Text] [Related]  

  • 22. First-trimester serum levels of the beta-subunit of human chorionic gonadotropin in a tubal molar pregnancy.
    Chase JS; Check JH; Nowroozi K; Wu CH
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):910. PubMed ID: 2445209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta subunit of chorionic gonadotropin in the control of benign trophoblastic disease].
    Vargas López E; Cano Vargas CE; Vázquez Matute LH; Aldana Bustamante A; Santini Villar AJ
    Ginecol Obstet Mex; 1982 Jan; 50(297):4-7. PubMed ID: 6292056
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence suggesting the trophoblastic origin of follicle-stimulating hormone, luteinizing hormone and prolactin in hydatidiform mole.
    Loganath A; Peh KL; Gunasegaram R; Ratnam SS
    Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):383-8. PubMed ID: 2460076
    [No Abstract]   [Full Text] [Related]  

  • 28. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis of patients with lung metastasis of invasive mole before evacuation of hydatidiform mole].
    Feng FZ; Xiang Y; Shan Y; Wan XR; Oang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):830-3. PubMed ID: 18476517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 33. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
    Kardana A; Cole LA
    Clin Chem; 1992 Jan; 38(1):26-33. PubMed ID: 1370771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased laminin-1 expression in hydatidiform mole.
    Iwahashi M; Muragaki Y; Ooshima A; Nakano R
    Mol Hum Reprod; 1997 Dec; 3(12):1107-11. PubMed ID: 9464856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotrophin in hydatidiform moles.
    Sciarra N
    J Obstet Gynaecol Br Commonw; 1970 May; 77(5):420-3. PubMed ID: 5427605
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J; Rosenshein NB; Block BS
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
    Yedema KA; Verheijen RH; Kenemans P; Schijf CP; Borm GF; Segers MF; Thomas CM
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):787-92. PubMed ID: 7681253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pitfalls in the management of trophoblastic disease in Africa.
    Mati JK; Sekade Kigondu C
    Adv Exp Med Biol; 1984; 176():409-16. PubMed ID: 6208764
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thyroid and hypophyseal steroid secretion in hydatidiform mole].
    Decocq J; Hennen G; Delahousse G; Delcroix M; Caquant F; Querleu D; Scholler R; Crépin G
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):744-6. PubMed ID: 100544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.